April 16, 2026
Medipha Santé takes a new step in its development with the marketing in France of SECNOL® (secnidazole).
Led with the support of the Athena Pharmaceuticals group, this launch illustrates our commitment to providing the French market with targeted therapeutic solutions, drawing on the Group's integrated industrial and pharmaceutical expertise.
Creator
June 3, 2025
Medipha Santé joins Athena Pharmaceutiques, thus opening a new strategic stage in its development.
This merger combines Medipha Santé's expertise in pharmaceutical marketing, regulatory affairs, and pharmacovigilance with Athena Pharmaceutiques' development and production capabilities. It strengthens our offering and allows us to provide integrated support, from drug development to commercialization in France and internationally.
Creator
March 7, 2022
Since 2004, Medipha Santé has been supporting players in the pharmaceutical industry through integrated expertise in regulatory affairs, pharmacovigilance, quality assurance and pharmaceutical operations.
Through personalized support and solutions tailored to each project, Medipha Santé helps to facilitate the marketing of essential and innovative medicines, for the benefit of healthcare professionals and patients.
Discover more about our expertise, our commitments and our vision in an article published by Le Figaro.
Creator